What is Mentari Therapeutics, Inc.?
, a biotechnology company, develops and provides therapies for migraine prevention.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.08B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.